These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2226347)
1. Effects of sc administration of recombinant human insulin-like growth factor I (IGF-I) on normal human subjects. Takano K; Hizuka N; Asakawa K; Sukegawa I; Shizume K; Demura H Endocrinol Jpn; 1990 Apr; 37(2):309-17. PubMed ID: 2226347 [TBL] [Abstract][Full Text] [Related]
2. Single sc administration of insulin-like growth factor I (IGF-I) in normal men. Hizuka N; Takano K; Asakawa K; Fukuda I; Sukegawa I; Shizume K; Demura H Adv Exp Med Biol; 1991; 293():105-12. PubMed ID: 1767729 [TBL] [Abstract][Full Text] [Related]
3. Repeated sc administration of recombinant human insulin-like growth factor I (IGF-I) to human subjects for 7 days. Takano K; Hizuka N; Shizume K; Asakawa K; Fukuda I; Demura H Growth Regul; 1991 Mar; 1(1):23-8. PubMed ID: 1842557 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse. Bianda TL; Hussain MA; Keller A; Glatz Y; Schmitz O; Christiansen JS; Alberti KG; Froesch ER Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219 [TBL] [Abstract][Full Text] [Related]
5. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. Clemmons DR; Smith-Banks A; Underwood LE J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015 [TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human insulin-like growth factor I administration in adults with growth hormone deficiency. Thorén M; Wivall-Helleryd IL; Hall K Acta Paediatr Suppl; 1993 Mar; 388():45-8. PubMed ID: 7687171 [TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886 [TBL] [Abstract][Full Text] [Related]
8. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment. Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561 [TBL] [Abstract][Full Text] [Related]
10. Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Miell JP; Taylor AM; Jones J; Buchanan CR; Rennie J; Sherwood R; Leicester R; Ross RJ Clin Endocrinol (Oxf); 1992 Dec; 37(6):542-51. PubMed ID: 1283730 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats. Lo HC; Hinton PS; Yang H; Unterman TG; Ney DM JPEN J Parenter Enteral Nutr; 1996; 20(3):171-7. PubMed ID: 8776688 [TBL] [Abstract][Full Text] [Related]